Restart Life Sciences Corp. NMLSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -209.00% | -110.73% | 26.37% | -4.15% | 74.22% |
| Total Depreciation and Amortization | 131.03% | 866.67% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 464.37% | -48.54% | 436.92% | -6.88% | -91.68% |
| Change in Net Operating Assets | -255.93% | 130.80% | -568.30% | 13.29% | 528.46% |
| Cash from Operations | -572.22% | 76.87% | -307.50% | -2.14% | 65.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 88.32% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -78.00% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -76.83% | -70.11% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 39.74% | -- | -- | -- | -- |
| Cash from Financing | -79.33% | -74.46% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.67% | -130.69% | 1,993.37% | -2.14% | -134.76% |